Development of a cyclodextrin-based aqueous cyclosporin A eye drop formulations
- PMID: 26220650
- DOI: 10.1016/j.ijpharm.2015.07.040
Development of a cyclodextrin-based aqueous cyclosporin A eye drop formulations
Abstract
Cyclosporin A (CyA) is a lipophilic, cyclic polypeptide drug with anti-inflammatory properties. It is used in topical treatment of dry eyes and is now commercially available in oil based surfactant containing eye drops. Surfactants can irritate the eye surface causing burning, itching and irritation of the conjunctiva, and oil-based drops can result in blurred vision. Thus, the aim of this study was to develop surfactant free aqueous 0.05% (w/v) CyA eye drops where the drug is present in an aqueous vehicle containing CyA/cyclodextrin (CyA/CD) nanoparticles. The effects of the natural α-, β- and γ-cyclodextrins (αCD, βCD and γCD), as well as of the water soluble hydroxypropyl derivatives of γCD and αCD (HPγCD, HPαCD) and randomly methylated βCD (RMβCD), were determined in pure water. αCD had the best solubilizing effect increasing the solubility of CyA above 0.05% upon addition of only 5% (w/v) αCD. γCD did not have as good solubilizing effect but was tested further due to its superior ability to form nanoparticles and its favorable toxicological profile. Seven eye drop formulations were prepared and tested. All contained 0.05% (w/v) CyA in addition to polyvinyl alcohol, benzalkonium chloride, disodium edetate and various amounts of CD (αCD, γCD and mixtures thereof). When the formulation contained only αCD most of the drug was dissolved but some small aggregates were formed with hydrodynamic diameter of about 6 and 155 nm. When the formulation contained only γCD negligible CyA/CD complexation occurred with most of the drug present as solid CyA particles. When the formulation contained a mixture of αCD and γCD, where αCD concentration was at least 3% (w/v), the entire drug content was dissolved in the media under formation of relatively large (100-2000 nm) CyA/CD nanoparticles. αCD solubilized the drug while γCD enhanced nanoparticle formation. The effect of polyvinyl alcohol, benzalkonium chloride and disodium edetate on the nanoparticle formation was also investigated and shown to have positive effect on the aggregate formation.
Keywords: Cyclodextrins; Cyclosporin A; Dry eye disease; Eye drops; Nanoparticles.
Copyright © 2015 Elsevier B.V. All rights reserved.
Similar articles
-
Formulations and toxicologic in vivo studies of aqueous cyclosporin A eye drops with cyclodextrin nanoparticles.Int J Pharm. 2017 Aug 30;529(1-2):486-490. doi: 10.1016/j.ijpharm.2017.07.044. Epub 2017 Jul 15. Int J Pharm. 2017. PMID: 28720540
-
Cyclodextrin-poloxamer aggregates as nanocarriers in eye drop formulations: dexamethasone and amphotericin B.Drug Dev Ind Pharm. 2016 Sep;42(9):1446-54. doi: 10.3109/03639045.2016.1141932. Epub 2016 Feb 16. Drug Dev Ind Pharm. 2016. PMID: 26765786
-
gammaCD/HPgammaCD: synergistic solubilization.Int J Pharm. 2008 Nov 3;363(1-2):217-9. doi: 10.1016/j.ijpharm.2008.07.011. Epub 2008 Jul 22. Int J Pharm. 2008. PMID: 18691643
-
γ-Cyclodextrin.Int J Pharm. 2017 Jan 10;516(1-2):278-292. doi: 10.1016/j.ijpharm.2016.10.062. Epub 2016 Oct 29. Int J Pharm. 2017. PMID: 27989822 Review.
-
Self-association of cyclodextrins and cyclodextrin complexes in aqueous solutions.Int J Pharm. 2019 Apr 5;560:228-234. doi: 10.1016/j.ijpharm.2019.02.004. Epub 2019 Feb 13. Int J Pharm. 2019. PMID: 30771468 Review.
Cited by
-
In Vitro and Ex Vivo Evaluation of Nepafenac-Based Cyclodextrin Microparticles for Treatment of Eye Inflammation.Nanomaterials (Basel). 2020 Apr 9;10(4):709. doi: 10.3390/nano10040709. Nanomaterials (Basel). 2020. PMID: 32283583 Free PMC article.
-
Achyranthis radix Extract-Loaded Eye Drop Formulation Development and Novel Evaluation Method for Dry Eye Treatment.Pharmaceutics. 2020 Feb 17;12(2):165. doi: 10.3390/pharmaceutics12020165. Pharmaceutics. 2020. PMID: 32079194 Free PMC article.
-
Phytic acid-loaded polyvinyl alcohol hydrogel promotes wound healing of injured corneal epithelium through inhibiting ferroptosis.Redox Biol. 2024 Oct;76:103354. doi: 10.1016/j.redox.2024.103354. Epub 2024 Sep 11. Redox Biol. 2024. PMID: 39298836 Free PMC article.
-
Topological Aspects of the Design of Nanocarriers for Therapeutic Peptides and Proteins.Pharmaceutics. 2019 Feb 21;11(2):91. doi: 10.3390/pharmaceutics11020091. Pharmaceutics. 2019. PMID: 30795556 Free PMC article. Review.
-
Antifungal Combination Eye Drops for Fungal Keratitis Treatment.Pharmaceutics. 2022 Dec 22;15(1):35. doi: 10.3390/pharmaceutics15010035. Pharmaceutics. 2022. PMID: 36678663 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources